Bicycle Therapeutics (BCYC) Revenue (2018 - 2026)

Bicycle Therapeutics has reported Revenue for 9 years, with the latest figure at $887000.0 in Q1 2026.

• For the quarter ending Q1 2026, Revenue fell 91.11% year-over-year to $887000.0; the trailing twelve-month figure through Mar 2026 stood at $63.5 million (up 146.85% YoY), and the FY2025 full-year result was $72.6 million, up 105.77% from the prior year.
• Revenue for Q1 2026 stood at $887000.0, down from $48.0 million in the prior quarter.
• The five-year high for Revenue was $48.0 million in Q4 2025, with the low at $887000.0 in Q1 2026.
• Historically, Revenue has averaged $8.8 million across 5 years, with a median of $5.4 million in 2023.
• Annual changes were most pronounced in 2025 — Revenue jumped 1193.28% — and 2026, when it sank 91.11%.
• Bicycle Therapeutics' Revenue stood at $8.4 million in 2022, then plunged by 36.54% to $5.3 million in 2023, then plunged by 30.44% to $3.7 million in 2024, then jumped by 1193.28% to $48.0 million in 2025, then slumped by 98.15% to $887000.0 in 2026.
• The last three Revenue figures came in at $887000.0 (Q1 2026), $48.0 million (Q4 2025), and $11.7 million (Q3 2025), per Business Quant data.